Stock Events

Stock Events

BeOne Medicines 

€22.40
87
-€0.60-2.61% 08:03 Today

Statistics

Day High
22.44
Day Low
22.2
52W High
25.6
52W Low
16.86
Volume
-
Avg. Volume
-
Mkt Cap
2.53B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q1 2026
Q2 2026
Next
0.07
0.09
0.11
0.14
Expected EPS
0.12576316443139682
Actual EPS
N/A

Financials

5.28%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.63BRevenue
244.23MNet Income

Analyst Ratings

308.14Average Price Target
The highest estimate is 344.50.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
91%
Hold
9%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IJ0.STU. It's not an investment recommendation.
Microsoft
10
MSFT
NVIDIA
10
NVDA
Meta Platforms
8
META
Broadcom
8
AVGO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap236.38B
Amgen competes in the biotechnology sector focusing on human therapeutics, including oncology, which overlaps with BeiGene's focus on cancer therapies.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company with a strong portfolio in oncology, competing directly with BeiGene's cancer treatment products.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. is known for its extensive range of cancer treatments and immunotherapy products, directly competing with BeiGene's oncology focus.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences, Inc. operates in the biopharmaceutical field, with significant investments in oncology and inflammatory diseases, making it a competitor to BeiGene.
Novartis
NVS
Mkt Cap304.1B
Novartis AG, with a broad portfolio including oncology, directly competes with BeiGene in the development and marketing of cancer therapies.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. is a global biopharmaceutical company with a diverse portfolio that includes oncology, competing with BeiGene in the cancer treatment market.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its pharmaceuticals division, focuses on oncology among other areas, competing with BeiGene in the cancer treatment space.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC has a strong focus on oncology, respiratory, cardiovascular, and metabolic diseases, making it a direct competitor to BeiGene in the oncology market.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals, Inc. is involved in biopharmaceuticals, focusing on oncology and other areas, which puts it in competition with BeiGene.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly and Company is a global healthcare leader that competes with BeiGene through its oncology division, developing cancer treatments.

About

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics. The company's main product is Brukinsa, which is a small-molecule drug that treats multiple forms of non-Hodgkin lymphoma and leukemia. The company conducts drug discovery, runs global clinical trials, and manufactures drugs independently. As of 2025, Brukinsa made up 74% of total revenue, while it has two other approved commercialized drugs in its portfolio, Beqalzi and Tevimbra. While Brukinsa has global leadership, the other two drugs generate revenue mostly from China. Based on Brukinsa, BeOne competes mainly with AbbVie and AstraZeneca. The company also has more than 50 drugs in clinical trials in its active pipeline, focused on other cancers.
Show more...
CEO
John V. Oyler
Employees
12000
Country
Cayman Islands
ISIN
CH1391448177
WKN
000A41ANK

Listings

SA
BR
B1ME34.SA
STU
DE
IJ0.STU
MU
DE
49BA.MU
STU
DE
49BA.STU

0 Comments

Share your thoughts

FAQ

What is BeOne Medicines stock price today?▼
The current price of IJ0.STU is €22.40 EUR — it has decreased by -2.61% in the past 24 hours. Watch BeOne Medicines stock price performance more closely on the chart.
What is BeOne Medicines stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange BeOne Medicines stocks are traded under the ticker IJ0.STU.
What is BeOne Medicines market cap?▼
Today BeOne Medicines has the market capitalization of 2.53B
When is the next BeOne Medicines earnings date?▼
BeOne Medicines is going to release the next earnings report on November 05, 2026.
What were BeOne Medicines earnings last quarter?▼
IJ0.STU earnings for the last quarter are 0.14 EUR per share, whereas the estimation was 0.11 EUR resulting in a +23.52% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is BeOne Medicines revenue for the last year?▼
BeOne Medicines revenue for the last year amounts to 4.63B EUR.
What is BeOne Medicines net income for the last year?▼
IJ0.STU net income for the last year is 244.23M EUR.
How many employees does BeOne Medicines have?▼
As of September 09, 2026, the company has 12,000 employees.
In which sector is BeOne Medicines located?▼
BeOne Medicines operates in the Health & Wellness sector.
When did BeOne Medicines complete a stock split?▼
BeOne Medicines has not had any recent stock splits.
Where is BeOne Medicines headquartered?▼
BeOne Medicines is headquartered in BASEL, Cayman Islands.